Drug Facts Label Should Be Required On Immediate Package – ONP’s Ganley
This article was originally published in The Tan Sheet
Executive Summary
Allowing the sale of OTC drugs in packages without Drug Facts labels on the immediate container poses risks for consumers, FDA Office of Nonprescription Products Director Charles Ganley says
You may also be interested in...
FDA Will Cooperate With OTC Drug Industry To Address Labeling Questions
FDA will work cooperatively with industry to address complications that may arise from the final rule on standardized OTC labeling announced March 11, Commissioner Jane Henney, MD, told the Nonprescription Drug Manufacturers Association annual meeting in Boca Raton, Fla. March 12 (see related stories, pp. 4-10). NDMA is being renamed the Consumer Healthcare Products Association.
Jurors' Answers In FTC Complaint Against Prevagen Might Form A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.